Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,244.40
(
-1.90%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
106.70
(
0.00%
)
Bitcoin
78,251.27
(
-1.02%
)
News Focus
News Focus
Post# of 257580
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

mcbio

Send PM Follow Ignore
Followers 69
Posts 6152
Boards Moderated 0
Alias Born 11/26/2008

mcbio

Re: DewDiligence post# 76262

Sunday, 06/14/2009 9:13:35 PM

Sunday, June 14, 2009 9:13:35 PM

Post# of 257580
PCYC - Factor VIIa inhibitor targeting cancer

http://www.pharmacyclics.com/wt/page/pci_27483

I know this may not be an apples-to-apples comparison, but do you see PCYC's approach in targeting a Factor VIIa inhibitor for cancer as similar in any way to what MNTA is doing with the M402 cancer program? Also, just curious if you or any others have any comments about the rationale behind PCYC's approach to treating cancer this way. Does this seem feasible?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today